Axcelis Technologies, Inc. (ACLS)

Axcelis Updates And Increases Q4 2020 Guidance

Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today provided updated financial guidance for the fourth quarter of 2020. The Company expects revenue for the fourth quarter of 2020 to be approximately $120 million, above the $110 million prior guidance. Gross margin of approximately 43% is up from the previous gross margin guidance of 41%. As a result, the Company expects earnings per diluted share of approximately $0.32, up from the previous guidance of approximately $0.21. Cash will be greater than $200 million. Strong performance by our CS&I business contributed to the strong revenue and gross margin.

• 
  Axcelis Technologies Shares Pop On Raised Guidance; Composite Rating Lifted

  Investor's Business Daily
• 
  Axcelis Technologies Sees RS Rating Jump To 80 As Tech Returns

  Investor's Business Daily

Axcelis To Participate In The 23rd Annual Needham Virtual Growth Conference

Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that Mary Puma, president and CEO, Kevin Brewer, executive vice president and CFO, and Doug Lawson, executive vice president of corporate marketing and strategy, will participate in the 23rd Annual Needham Virtual Growth Conference, taking place January 11-15, 2021.

Axcelis To Participate In The 12th Annual CEO Investor Summit 2020

Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that Mary Puma, president and CEO, Kevin Brewer, executive vice president and CFO, and Doug Lawson, executive vice president of corporate marketing and strategy, will participate in the 12th Annual CEO Investor Summit, being held virtually this year on December 16, 2020.